Trial · NCT07555730
Registered outcomes32
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 32
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Body weight change (kg) | Change from randomization (week 20) to week 72 | Weight will be measured to the nearest 0.1 kg |
| Secondary | Percent change in body weight | Change from randomization (week 20) to week 72 | Percent change from week 20 to week 72 |
| Secondary | Body mass index | Change from randomization (week 20) to week 72 | Weight / Height\^2 (kg/m²) |
| Secondary | Waist and hip circumference | Change from randomization (week 20) to week 72 | Waist and hip circumference will be measured to the nearest 0.1cm |
| Secondary | Body fat percentage | Change from randomization (week 20) to week 72 | Change in body fat percentage (BF%) from randomization to the week 72 |
| Secondary | Skeletal muscle mass | Change from randomization (week 20) to week 72 | Change in skeletal muscle mass (SMM) from randomization to the week 72, measured in kg |
| Secondary | Fat mass | Change from randomization (week 20) to week 72 | Change in fat mass (FM) from randomization to the week 72, measured in kg |
| Secondary | Fat free mass | Change from randomization (week 20) to week 72 | Change in fat free mass (FFM) from randomization to the week 72, measured in kg |
| Secondary | Blood pressure | Change from randomization (week 20) to week 72 | Blood pressure (systolic/diastolic) will be measured with a digital blood pressure monitor in sitting position (mmHg) |
| Secondary | Concentration of glycated hemoglobin (HbA1c) | Change from randomization (week 20) to week 72 | Concentration of HbA1c, measured in the percentage of hemoglobin |
| Secondary | Concentration of fasting glucose | Change from randomization (week 20) to week 72 | Concentration of fasting glucose, measured in mmol/L |
| Secondary | Concentration of Insulin | Change from randomization (week 20) to week 72 | Concentration of fasting insulin, measured in mU/L |
| Secondary | Concentration of C-peptide | Change from randomization (week 20) to week 72 | Concentration of fasting C-peptide, measured in mmol/L |
| Secondary | Concentration of blood lipids | Change from randomization (week 20) to week 72 | Concentration of blood lipids (total cholesterol, triglycerides, low-density lipoprotein cholesterol, high density lipoprotein cholesterol), measured in mmol/L |
| Secondary | Body weight change (kg) | Change from baseline (week 0) to week 72 | Weight will be measured to the nearest 0.1 kg |
| Secondary | Percent change in body weight | Change from baseline (week 0) to week 72 | * Percent change from week 0 to week 72 * Percentage of participants who achieve ≥5% body weight reduction * Percentage of participants who achieve ≥10% body weight reduction * Percentage of participants who achieve ≥15% body weight reduction |
| Secondary | Waist and hip circumference | Change from baseline (week 0) to week 72 | Waist and hip circumference will be measured to the nearest 0.1cm |
| Secondary | Concentration of glycated hemoglobin (HbA1c) | Change from baseline (week 0) to week 72 | Concentration of HbA1c, measured in the percentage of hemoglobin. |
| Secondary | Concentration of blood lipids | Change from baseline (week 0) to week 72 | Concentration of blood lipids (total cholesterol, triglycerides, low-density lipoprotein cholesterol, high density lipoprotein cholesterol), measured in mmol/L |
| Other | Concentration of high-sensitivity C-reactive protein (hs-CRP) | Change from baseline (week 0) to week 72 | Concentration of hs-CRP, measured in mU/L |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07555730/registered